ПЕРСПЕКТИВЫ ОПРЕДЕЛЕНИЯ ВАРИАБЕЛЬНОСТИ РИТМА СЕРДЦА И ДЛИТЕЛЬНОСТИ ИНТЕРВАЛА Q-T ПРИ РЕВМАТОИДНОМ АРТРИТЕ И СИСТЕМНОЙ КРАСНОЙ ВОЛЧАНКЕ

1. <div><p>Попкова Т.В., Новикова Д.С., Насонов Е.Л. Атеросклероз при ревматических заболеваниях. В кн.: Ревматология: клинические рекомендации. M.: ГЭОТАР-Медиа, 2010; 678-702.</p><p>Peters M.J., Symmons D.P., McCarey D. W. et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other types of inflammatory arthritis - TASK FORCE «Cardiovascular risk management in RA». Ann Rheum Dis 2010; 69(2): 325-31.</p><p>Meune C., Touze E., Trinqurte L. et al. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analisis of cohort studies. Rheumatology 2009; 48(10): 1309-13.</p><p>Westerweel P.E., Remco K.M., Luyten C. et al. Premature Atherosclerotic Cardiovascular Disease in Systemic Lupus Erythematosus. Arthr Rheum 2007; 56(5): 1384-96.</p><p>Chung C.P., Oeser A., Avalos I. et al. Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthr Res Ther 2006; 8(6): R186.</p><p>Попкова Т.В., Новикова Д.С., Насонов E. Л. Атеротромбоз при аутоиммунных заболеваниях: современное состояние проблемы. Consilium Medicum 2008; 10(11): 128-35.</p><p>Full L., Ruisanchez C., Monaco C. The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus. Arthr Res Ther 2009; 11(2): 217.</p><p>Leuven S.I., Franssen R., Kastelein J.J. et al. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology 2008; 47: 3-7.</p><p>Montecucco F., Mach F. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology 2009; 48: 11-22.</p><p>Cook S., Togni M., Schaub M. et al. High heart rate: a cardiovascular risk factor? Eur Heart J 2006; 27: 2387-93.</p><p>Kaufman C.L., Kaiser D.R., Steinberger J. et al. Relationships between heart rate variability, vascular function, and adiposity in children. Clin Auton Res 2007; 17(3): 165-71.</p><p>Ожолов С.Ф., Малкина Т.А. Клиническое значение оценки вариабельности ритма сердца. Сердце 2002; 2: 72-5.</p><p>Чернышева Т.Е., Гурьева И.В., Алтунбаев Н.А. и др. Диабетическая нейропатия (патогенез, диагностика, лечение). М.: Медпрактика-М, 2005.</p><p>Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043-65.</p><p>Crawford M.H., Bernstein S.J., Deedwania P.C. et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology. JACC 1999; 34(3): 912-48.</p><p>Huikuri H.V., Mдkikallio T., Airaksinen K.E. et al. Measurement of heart rate variability: a clinical tool or a research toy? JACC 1999; 34(7): 1878-83.</p><p>Jose A.D., Taylor R.R. Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. J Clin Invest 1969; 48(11): 2019-31.</p><p>Hirsch J.A., Bishop B. Respiratory sinus arrhythmia in humans: how breathing pattern modulates heart rate. Am J Physiol 1981; 241(4): 620-9.</p><p>Eckberg D.L. Human sinus arrhythmia as an index of vagal cardiac outflow. J Appl Physiol 1983; 54(4): 961-6.</p><p>Соколов С.Ф., Малкина Т.А., Алексеева Ю.М. и др. Показатели вариабельности ритма сердца в норме у взрослых: коррекция по возрасту и частоте сердечных сокращений. Функц. диагн. 2007; 3: 6-16.</p><p>Bigger J.T., Fleiss J.L., Steinman R.C. et al. RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation 1995; 7: 1936-43.</p><p>Бойцов С.А., Белозерцева И.В., Кучмин А.Н. и др. Возрастные особенности изменения показателей вариабельности сердечного ритма у практически здоровых лиц. Вестн. аритмол. 2000; 26: 57-60.</p><p>Akselrod S. Power spectrum analysis of heart rate variability in dogs was related to progressive autonomic blockade. References also to original studies by Sayers on the spectral components of heart rate variability. Science 1981; 213: 221-4.</p><p>Akselrod S. Components of heart rate variability. Basic Studies. From: Malik M., Camm A.J. Heart rate variability. Armonk: Futura Publishing Company, Inc., 1995; 147-60.</p><p>Akselrod S. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981; 213: 220-2.</p><p>Bigger J.T. Components of heart rate variability measured during healing of acute myocardial infarction. Am J Cardiol 1988; 18: 464-72.</p><p>Malik M., Camm A.J. Heart rate Variability. Clin Cardiol 1990; 13: 570-6.</p><p>Malliani A. Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms. Br Heart J 1994; 71: 1-2.</p><p>Wolf M.M., Varigos G.A., Hunt D., Sloman J.G. Sinus arrhythmia in acute myocardial infarction. Med J Aust 1978; 2(2): 52-3.</p><p>Kleiger R.E. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256-62.</p><p>Bigger J.T. Frequency domain measures of heart period variability and mortality rate after myocardial infarction. Circulation 1992; 85: 164-71.</p><p>Tapanainen J.M., Thomsen P.E., Kober L. et al. Fractal analysis of heart rate variability and mortality after an acute myocardial infarction. Am J Cardiol 2002; 90: 347-52.</p><p>Yi G., Goldman J.H., Keeling P.J. et al. Heart rate variability in idiopathic dilated cardiomyopathy: relation to disease severity and prognosis. Heart 1997; 77(2): 108-14.</p><p>Nolan J., Batin P.D., Andrews N. et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-Heart). Circulation 1998; 8: 1510-6.</p><p>Schroeder E.B., Chambless L.E., Liao D. et al. Diabetes, glucose, insulin and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2005; 28(3): 668-74.</p><p>Ko S.H., Song K.H., Park S.A. et al. Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with Type 2 diabetes mellitus: a 7-year follow-up study. Diabet Med 2008; 25(10): 1171-7.</p><p>Fagard R.H., Stolarz K., Kuznetsova T. et al. Sympathetic activity, assessed by power spectral analysis of heart rate variability, in white-coat, masked and sustained hypertension versus true normotension. J Hypertens 2007; 25(11): 2280-5.</p><p>Huikuri H., Ylitalo A., Pikkujamsa S.M. et al. HR variability in sistemic hypertension. Am J Cardiol 1996; 77(12): 1073-7.</p><p>Park S.K., Schwartz J., Weisskopf M. et al. Low-level lead exposure, metabolic syndrome, and heart rate variability: The VA normative aging study. Environ. Health Perspect 2006; 114(11): 1718-24.</p><p>Макаров Л.М. Противоречивые аспекты анализа вариабельности ритма сердца при холтеровском мониторировании. В кн.: Клинические и физиологические аспекты ортостатических расстройств. М., 2001; 89-93.</p><p>Report and recommendations of the San Antonio conference on diabetic neuropathy. Consensus statement. Diabetes 1988; 37(7): 1000-4.</p><p>Никитин Ю.П., Кузнецов А.А. Дисперсия интервала Q-T. Кардиология 1998; 5: 58-63.</p><p>Макаров Л.М., Чупрова С.Н., Киселева И.И. Сравнение способов измерения интервала Q-T и их клиническое значение. Кардиология 2004; 5: 71-3.</p><p>Никитин Ю.П., Кузнецов А.А., Малютина С.К. и др. Прогностическое значение длительности и дисперсии интервалов Q-T и R-R в общей популяции Новосибирска. Кардиология 2002; 2: 76-83.</p><p>Glancy J.M., Garrant C.J., Woods K.L., de Bono D.P. QT dispersion and mortality after myocardial infarction. Lancet 1995; 345: 1553-5.</p><p>Higham P.D., Furniss S.S., Campbell R. et al. QT dispersion and components of the QT interval in ischemia and infarction. Br Heart J 1995; 73: 32-6.</p><p>Макарычева О.В., Васильева Е.Ю., Радзевич А.Э., Шпектор А.В. Динамика дисперсии интервала QT при остром инфаркте миокарда и ее прогностическое значение. Кардиология 1998; 7: 43-6.</p><p>Пархоменко А.Н., Шумаков А.В., Иркин О.И. Интервал Q-T ЭКГ: значение его дисперсии в качестве маркера аритмогенеза. Кардиология 2001; 4: 83-6.</p><p>Dobson C.P., Larovere M.T., Olsen C. et al. 24-Hour QT variability in heart failure. J Electrocardiol 2009; 42(6): 500-4.</p><p>Watanabe E., Arakawa T., Uchiyama T. et al. Prognostic significance of circadian variability of RR and QT intervals and QT dynamicity in patients with chronic heart failure. Heart Rhythm 2007; 4(8): 999-1005.</p><p>Рябыкина Г.В., Шишова Т.А., Лаптев Д.Н. и др. Динамика артериального давления, вариабельности ритма сердца и QTc у больных с метаболическим синдромом при лечении селективным β-блокатором и бигуанидами. Системные гипертензии 2009; 3: 38-56.</p><p>Soydinc S., Davutoglu V., Akcay M. et al. Uncomplicated metabolic syndrome is associated with prolonged electrocardiographic QTc interval and QTc dispertion. Ann Noninvasive Electrocardiol 2006; 11(4): 313-7.</p><p>Фурман Н.В., Шматова С.С., Довгалевский П.Я. и др. Анализ факторов, влияющих на величину дисперсии интервала QT, у пациентов со стабильной стенокардией. Клин. мед. 2009; 7: 20-3.</p><p>Padmanabhan S., Silvet H., Amin J. et al. Prognostic value of QT interval and QT dispersion in patients with left ventricular systolic dysfunction: results from a cohort of 2265 patients with an ejection fraction of 40%. Am Heart J 2003; 145(1): 132-8.</p><p>Ziegler D., Zentai C.P., Perz S. et al. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care 2008; 31(3): 556-61.</p><p>Elming H., Holm E., Jun L. et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiacmortality and morbidity in a population of Danish citizens. Eur Heart J 1998; 19: 1391-400.</p><p>De Bruyne M.C., Hoes A.W., Kors J.A. et al. Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. Eur Heart J 1999; 20: 278-84.</p><p>Пшеничников И., Шипилова Т., Карай Д. и др. Связь интервала QT и дисперсии интервала QT с факторами, определяющими прогноз сердечно-сосудистой заболеваемости и смертности в популяции женщин 56-65 лет города Таллин. Кардиология 2009; 4: 46-51.</p><p>Darbar D., Luck J., Davidson N.C. et al. Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. Br Med J 1996; 312: 874-8.</p><p>Malik M., Hnatkova K., Schmidt A. et al. Accurately measured and properly heartrate corrected QTc intervals show little daytime variability. Heart Rhythm 2008; 5(10): 1424-31.</p><p>Шитов В.Н., Меркулова И.Н., Соколов С.Ф., Самойленко Л.Е. Частотная зависимость интервала Q-T в норме и при инфаркте миокарда. http://www.mediasphera.ru/journals///4487/</p><p>Макаров М. Оценка интервала QT при холтеровском мониторировании. www.medass.ru/news/con_2003/p345_356.doc</p><p>Osterhues H. QT-variability: Clinical results and prognostic significance. In: Advances in noninvasive electrocardiographic monitoring technigues. Eds H. Osterhues, V. Hombach, A. Moss. Dordrecht-Boston-London: Kluwer Academ. Publ., 2000; 143-53.</p><p>Molnar J., Rosenthal J., Weiss S., Somberg C. QT interval dispersion in healthy subjects and survivors of sudden cardiac death: Circadian variation and twenty four-hour assesement. Am J Cardiol 1997; 79(1): 1190-3.</p><p>Zareba W., Moss A., Badilini F. Dispersion of repolarisation: Noninvasive marker of nonuniform reconery of ventricular exitability. In: Noninvasive Electrocardiology. Clinical aspects of Holter monitoring. Eds A. Moss, S. Stern. Cambridge, UK: Saunders Cо, University Press, 1997; 405-19.</p><p>Сычев О.С., Епанчинцева О.А., Романова Е.Н. Интервал Q-T и показатели вариабельности ритма сердца у больных с ишемической болезнью сердца и желудочковыми аритмиями. http://www.rql.kiev.ua/cardio_j/2003/5/sych &lt;http://www.rql.kiev.ua/cardio_j/2003/5/sych&gt; ov.htm</p><p>Ridker P.M., Rifai N., Stampfer M.J. et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767-72.</p><p>Pearson T.A., Mensah G.A., Alexander R.W. et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.</p><p>Насонов Е.Л. Иммунологические маркеры атеросклероза. В кн.: Антифосфолипидный синдром. М.: Литтерра, 2004; 278-98.</p><p>Danesh J., Kaptoge S., Mann A.G. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Medicine 2008; 5(e78): 0600-0610.</p><p>Kuo L.T., Yang N.I., Cherng W.J. Serum interleukin-6 levels, not genotype, correlate with coronary plaque complexity. Int Heart J 2008; 49: 391-402.</p><p>Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-43.</p><p>Hansson G.K. Inflammation, atherosclerosis and coronary artery disease. N Eng J Med 2005; 352: 1685-95.</p><p>Sajadieh A., Nielsen O., Rusmussen V. et al. Increased heart rate and reduced heart rate variability are associated with subclinical inflammation in middle-age and elderly subjects with no apparent heart diseases. Eur Heart J 2004; 25: 363-70.</p><p>Kon H., Nagano M., Tanaka F. et al. Association of decreased variation of R-R interval and elevated serum C-reactive protein level in a general population in Japan. Int Heart J 2006; 47: 867-76.</p><p>Madsen T., Christensen J.H., Toft E., Schmidt E.B. C-reactive protein is associated with heart rate variability. Ann Noninvasive Electrocardiol 2007; 12(3): 216-22.</p><p>Von Kдnel R., Nelesen R.A., Mills P.J. et al. Relationship between heart rate variability, interleukin-6, and soluble tissue factor in healthy subjects. Brain Behav Immun 2008; 22: 461-8.</p><p>Sloan R.P., McCreath H., Tracey K.J. et al. RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 2007; 13: 178-84.</p><p>Stein P.K., Barzilay J.I., Chaves P.H. et al. Higher levels of inflammation factors and greater insulin resistance are independently associated with higher heart rate and lower heart rate variability in normoglycemic older individuals: the Cardiovascular Health Study. J Am Geriatr Soc 2008; 2: 315-21.</p><p>Marsland A.L., Gianaros P.J., Prather A.A. et al. Stimulated production of proinflammatory cytokines covaries inversely with heart rate variability. Psychosom Med 2007; 8: 709-16.</p><p>Lampert R., Bremner J.D., Su S. et al. Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am Heart J 2008; 156(759): e1-e7.</p><p>Thaver J., Fischer J.E. Heart rate variability, overnight urinary norepinephrine and C-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults. J Intern Med 2009; 265(4): 439-47.</p><p>Haensel A., Mills P.J., Nelesen R.A. The relationship between heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinol 2008; 33: 1305-12.</p><p>Von Kдnel R., Thayer J.F., Fischer J.E. Nighttime vagal cardiac control and plasma fibrinogen levels in a population of working men and women. Ann Noninvasive Electrocardiol 2009; 14(2): 176-84.</p><p>Singh P., Hawkley L.C., McDade T.W. et al. Autonomic tone and C-reactive protein: a prospective population-based study. Clin Auton Res 2009; 19(6): 367-74.</p><p>Janszky I., Ericson M., Lekander M. et al. Inflammatory markers and heart rate variability in women with coronary heart diseases. J Intern Med 2004; 5: 421-8.</p><p>Hamaad A., Sosin M., Blann A.D. et al. Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variability. Clin Cardiol 2005; 28(12): 570-6.</p><p>Nolan R.P., Reid G.J., Seidelin P.H. et al. C-reactive protein modulates vagal heart rate control in patients with coronary artery disease. Clin Sci 2007; 112(8): 449-56.</p><p>Lanza G.A., Sgueglia G.A., Cianflone D. et al. Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am J Cardiol 2006; 97(12): 1702-6.</p><p>Psychari S.N., Apostolou T.S., Iliodromitis E.K. et al. Inverse relation of C- reactive protein levels to heart rate variability in patients after acute myocardial infarction. Hellenic J Cardiol 2007; 48(2): 64-71.</p><p>Shebab A.M., MacFadyen R.J., McLaren M. et al. Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study. Heart 2004; 90: 1263-8.</p><p>Aronson D., Mittleman M.A., Burger A. J. Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 2001; 12: 294-300.</p><p>Diakakis G.F., Parthenakis F.I., Mavrakis H.E. et al. Association of impaired glucose tolerance with increased heart rate and subclinical inflammation. Hellenic J Cardiol 2005; 46(6): 394-401.</p><p>Anan F., Takahashi N., Nakagava M. et al. High-sensitive C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Metabolism 2005; 54(4): 552-8.</p><p>Shinohara T., Tacahashi N., Yufu K. et al. Role of interleukine-6 levels in cardiovascular autonomic dysfunction in type 2 diabetic patients. Eur J Nucl Med Mol Imaging 2008; 35: 1616-23.</p><p>Gonzalez-Clemente J.M., Vilardell C., Broch M. et al. Lower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes. Eur J Endocrinol 2007; 157(1): 31-8.</p><p>Brunner E.J., Hemingway H., Walker B. R. et al. Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome: Nested Case-Control Study. Circulation 2002; 106: 2659-65.</p><p>Lombardi F. Sympathetic activation and subclinical inflammation: a new combination to identify high risk subjects. Eur Heart J 2004; 25: 359-60.</p><p>Sajadieh A., Nielsen O.W., Rasmussen V. et al. C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease. J Intern Med 2006; 260(4): 377-87.</p><p>Elencov I.J., Wilder R.L., Chroussos G.P. et al. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000; 52: 595-638.</p><p>Elenkov I.J., Chrousos G.P. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann NY Acad Sci 2002; 966: 290-303.</p><p>Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007; 117: 289-96.</p><p>Thayer J.F. Vagal tone and the inflammatory reflex. Cliv Clin J Med 2009; 76(2): 23-6.</p><p>Tracey K.J., Ulloa L. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004; 10: 1216-21.</p><p>Weber C.S., Thayer J.F., Rudat M. et al. Low vagal tone is associated with impaired post stress recovery of cardiovascular, endocrine, and immune markers. Eur J Appl Physiol 2010 (epub. ahead of print).</p><p>Hamer M., Steptoe A. Association between physical fitness, parasympathetic control, and proinflammatory responses to mental stress. Psychosom Med 2007; 69(7): 660-6.</p><p>Holman A.J., Ng E. Heart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritis. Auton Neurosci 2008; 143(1-2): 58-67.</p><p>Straub R.H., Pongratz G., Hirvonen H. et al. Acute cold stress in rheumatoid arthritis inadequately activates stress responses and induces an increase of interleukin 6. Ann Rheum Dis 2009; 68(4): 572-8.</p><p>Dickens C., Psycii M.R., Jackson J. Association of depression and rheumatoid arthritis. Psychosomatics 2003; 44(3): 209-15.</p><p>Treharne G.J., Hale E.D., Lyons A.C. et al. Cardiovascular disease and psychological morbidity among rheumatoid arthritis patients. Rheumatology 2005; 44: 241-6.</p><p>Лисицына Т.А., Вельтищев Д.Ю., Серавина О.Ф. и др. Распространенность психических нарушений у больных системной красной волчанкой: связь с активностью заболевания и сопутствующими хроническими расстройствами. Тер. арх. 2009; 6: 10-6.</p><p>Wolfe F., Michaud K., Li T., Katz R.S. Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia. J Rheumatol 2010; 37(2): 305-15.</p><p>Ang D.C., Choi H., Kroenke K., Wolfe F. Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatology 2005; 32: 1013-9.</p><p>Scherrer J.F., Virgo K.S., Zeringue A. et al. Depression increases risk of incident myocardial infarction among Veterans Administration patients with rheumatoid arthritis. Gen Hosp Psychiatry 2009; 31(4): 353-9.</p><p>Greco C.M., Kao A.H., Sattar A. et al. Association between depression and coronary artery calcification in women with systemic lupus erythematosus. Rheumatology 2009; 48(5): 576-81.</p><p>Pongratz G., Zietz B., Gluck T. et al. Corticotropin-releasing factor modulates cardiovasclar and pupillary autonomic reflexes in man: is there a link to inflammation-induced autonomic nervous hyper-reflexia? Ann NY Acad Sci 2002; 966: 373-83.</p><p>Arlt J., Jahn H., Kellner M. et al. Modulation of sympathetic activity by corticotrophin-releasing hormone and atrial natriuretic peptide. Neuropeptides 2003; 37(6): 362-8.</p><p>Kemp A.H., Quintana D.S., Gray M.A. et al. Impact of depression and antidepressant treatment on heart rate variability: A review and meta-analysis. Biol Psychiatry 2010 (epub. ahead of print).</p><p>Brown A.D., Barton D.A., Lambert G.W. Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment. CNS Drugs 2009; 23(7): 583-602.</p><p>Pizzi C., Manzoli L., Mancini S., Costa G.M. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. Eur Heart J 2008; 29(9): 1110-7.</p><p>Carney R.M., Freedland K.E. Depression and heart rate variability in patients with coronary heart disease. Clev Clin J Med 2009; 76(2): 13-7.</p><p>Glassman A.H., Bigger J.T., Gaffney M., van Zyl L.T. Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement. Arch Gen Psychiatry 2007; 64(9): 1025-31.</p><p>Carney R.M., Blumenthal J.A., Freedland K.E. et al. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med 2005; 165(13): 1486-91.</p><p>Taylor C.B., Youngblood M.E., Catellier D. et al. ENRICHD Investigators. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005; 62(7): 792-8.</p><p>Dawood T., Lambert E.A., Barton D.A. et al. Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk. Hypertens Res 2007; 30(4): 285-93.</p><p>Evrengьl H., Dursunoglu D., Cobankara V. et al. Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int 2004; 24(4): 198-202.</p><p>Парнес Е.Я., Красносельский М.Я., Цурко В.В. и др. Долгосрочный прогноз у больных ревматоидным артритом в зависимости от исходной вариабельности сердечного ритма. Тер. aрх. 2005; 9: 77-80.</p><p>Stojanovich L., Milovanovich B., de Luka S.R. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjogren syndrome and other autoimmune diseases. Lupus 2007; 16(3): 181-5.</p><p>Anichkov D.A., Shostak N.A., Ivanov D.S. Heart rate variability is related to disease activity and smoking in rheumatoid arthritis patients. Int J Clin Pract 2007; 61: 777-83.</p><p>Novikova D.S., Popkova T.V., Gavva T.N. et al. Comparative evaluations of heart rate variability parameters, disease activity and markers of inflammation in patients with rheumatoid arthritis. Ann Rheum Dis 2008; 67(Suppl. II): 308.</p><p>Новикова Д.С., Попкова Т.В., Маркелова Е.И. и др. Клиническое значение оценки вариабельности ритма сердца у больных ревматоидным артритом. Клин. мед. 2009; 1: 27-32.</p><p>Петрова Е.В., Дмитриева Н.С., Мясоедова С.Е. Эластические свойства сосудов при ревматоидном артрите. Особенности артериальной гипертонии при ревматоидном артрите. Сб. матер. V съезда ревматологов России. М., 2009; 86.</p><p>Аничков Д.А., Платонова А.А. Клиническое значение показателей вариабельности сердечного ритма (по данным 5-минутных и 24-часовых записей ЭКГ) у больных ревматоидным артритом. Рацион. фармакотер. 2009; 1: 77-82.</p><p>Никитина Н.М., Ребров А.П. Взаимосвязь показателей вариабельности ритма сердца и толщины интима-медиа сонных артерий у больных ревматоидным артритом. Сб. матер. V съезда ревматологов России. М., 2009; 80.</p><p>Chung C.P., Oeser A., Raggi P. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthr Rheum 2005; 52(10): 3045-53.</p><p>Gazi I.F., Boumpas D.T., Mikhailidis D. et al. Clustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins. Clin Exp Rheumatol 2007; 25: 102-11.</p><p>Mussalo H., Vannien E., Ikaheimo R. et al. Heart rate variability and its determinants in patients with severe or mild essential hypertension. Clin Physiol 2001; 21: 594-604.</p><p>Dietrich D., Schindler C., Schwartz J. et al. Heart rate variability in an ageing population and its association with lifestyle and cardiovascular risk factors: results of the SAPALDIA study. Europace 2006; 8: 521-9.</p><p>Guizar J.M., Ahuatzin R., Amador N. Heart autonomic dysfunction in overweight adolescents. Indian Pediatr 2005; 42(5): 464-9.</p><p>Sloan R.P., Huang M.H., McCreath H. et al. Cardiac autonomic control and the effects of age, race, and sex: the CARDIA study. Auton Neurosci 2008; 30: 78-85.</p><p>Escalante A., Haas R.W., del Rincon I. et al. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role for comorbidity and systemic inflammation. Arch Intern Med 2005; 167: 1624-9.</p><p>Wranicz J.K., Cygankiewich I., Zielinska M. et al. Non-invasive evaluation in patients with systemic lupus erythemato- sus. J Med 2001; 32: 195-206.</p><p>Lagana B., Schillaci O., Tubani L. et al. Lupus carditis: evaluation with technetium- 99m MIBI myocardial SPECT and heart rate variability. Angiology 1999; 50(2): 143-8.</p><p>Lagana B., Gentile R., Vella C. et al. Heart and autonomic nervous system in connective tissue disorders. Recenti Prog Med 1997; 88(12): 579-84.</p><p>Laversuch C.J., Seo H., Modarres H. et al. Reduction in heart rate variability in patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 1540-4.</p><p>Lagana B., Tubani L., Maffeo N. et al. Heart rate variability and cardiac autonomic function in patients with systemic lupus erythematosus. Lupus 1996; 5(1): 44-8.</p><p>Stein K.S., McFarlane I.C., Goldberg N. et al. Heart rate variability in patients with systemic lupus erythematosus. Lupus 1996; 5(1): 49-55.</p><p>Aydemir M., Yazisiz V., Basarici I. et al. Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus. Lupus 2009 (epub. ahead of print).</p><p>Huang S.T., Chen G.Y., Wu C.H. et al. Effect of disease activity and position on autonomic nervous modulation in patients with systemic lupus erythematosus. Clin Rheumatol 2008; 27(3): 295-300.</p><p>Новикова Д.С., Попкова Т.В., Панафидина Т.А. и др. Клиническое значение оценки вариабельности ритма сердца у больных системной красной волчанкой. Тер. арх. 2008; 9: 68-72.</p><p>Новикова Д.С., Попкова Т.В., Панафидина Т.А. и др. Роль воспаления в развитии кардиальной автономной дисфункции при системной красной волчанке. Науч.-практич. ревматол. 2008; 6: 4-10.</p><p>Alkaabi J.K., Ho M., Levison R. et al. Rheumatoid arthritis and macrovascular disease. Rheumatology 2003; 42: 292-7.</p><p>Gцldeli O., Dursun E., Komsuoglu B. et al. Dispersion of ventricular repolarization: a new marker of ventricular arrhythmias in patients with rheumatoid arthritis. J Rheumatol 1998; 25(3): 447-50.</p><p>Pirildar T., Sekuri C., Utьk O. et al. QT dispersion in rheumatoid arthritis patients with and without Sjц gren's syndrome. Clin Rheumatol 2003; 22(3): 225-8.</p><p>Cindas A., Gцkce-Kutsal Y., Tokgц zoglu L. et al. QT dispersion and cardiac involvement in patients with rheumatoid arthritis. Scand J Rheumatol 2002; 31(1): 22-6.</p><p>Lazzerini P.E., Capecchi P.L., Guideri F. et al. Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease. Am J Cardiol 2007; 100(6): 1029-34.</p><p>Yavuz B., Atalar E., Karadag O. et al. QT dispersion increases in patients with systemic lupus erythematosus. Clin Rheumatol 2007; 26(3): 376-9.</p><p>Cardoso C.R., Sales M.A., Papi J.A. et al. QT-interval parameters are increased in systemic lupus erythematosus patients. Lupus 2005; 14(10): 846-52.</p><p>Yavuzkir M., Ozturk A., Dagli N. et al. Effect of ongoing inflammation in rheumatoid arthritis on P-wave dispersion. J Int Med Res 2007; 35(6): 796-802.</p><p>Hall F.C., Dalbeth N. Disease modification and cardiovascular risk reduction: two sides of the same coin. Rheumatology 2005; 44: 1473-82.</p><p>Hurlimann D., Forster A., Noll G. et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002; 106: 2184-7.</p><p>Gonzalez-Juanatey C., Testa A., Garcia-Castelo A. et al. Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody. Arthr Rheum 2004; 51: 447-50.</p><p>Van Doornum S., McColl G., Wicks I.P. Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. Rheumatology 2005; 44: 1428-32.</p><p>Angel K., Provan S.A., Agewall S. et al. TNF-alpha antagonists reduce arterial stiffness in patients with rheumatoid arthritis and related arthropaties: a controlled study. Ann Rheum Dis 2008; 67(Suppl. II): 160.</p><p>Cypiene A., Laucevicius A., Venalis A. Non-invasive assessment of arterial stiffness indices by applanation tonometry and pulse wave analysis in patients with rheumatoid arthritis treated with TNF-alpha blocker remicade (infliximab). Proc West Pharmacol Soc 2007; 50: 119-22.</p><p>Maki-Petaja K.M., Hall F.C., Booth A.D. et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 2006; 114: 1185-92.</p><p>Del Porto F., Lagana B., Lai S. et al. Response to anti-tumor necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology 2007; 46: 1111-5.</p><p>Jacobsson L.T., Turesson C., Gulfe A. et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 1213-8.</p><p>Dixon W.G., Watson K.D., Lunt M. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthr Rheum 2007; 56: 2905-12.</p><p>Naranjo A., Sokka T., Descalzo M.A. et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthr Res Ther 2008; 10: R30.</p><p>Lazzerini P.E., Acampa M., Hammoud M. Arrythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, crossover study in patients with chronic arthritis. J Rheum 2008; 35(10): 1958-65.</p><p>Новикова Д.С., Попкова Т.В., Линева О.Г. и др. Динамика показателей вариабельности ритма сердца у больных ревматоидным артритом на фоне лечения ритуксимабом. Тер. арх. 2010 (в печати).</p><p>Novikova D.S., Popkova T.V., Lineva O.G. et al. Effect of rituximab treatment on heart rate variability in patients with rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 2009; 68(Suppl. 3): 568.</p></div><br />